Viviana De Luca | Biology and Life Sciences | Women Researcher Award

Dr. Viviana De Luca | Biology and Life Sciences | Women Researcher Award

Dr. Viviana De Luca | Biology and Life Sciences | Research fellow at University of Sannio RCOST | Italy

Dr. Viviana De Luca is a distinguished researcher in biological, environmental, and health sciences, recognized for her advanced expertise in enzymology, carbonic anhydrase biology, antimicrobial drug discovery, and translational biomedical research. Her education encompasses advanced doctoral training in biology and environmental and health sciences, earned from leading Italian universities, with research conducted at prominent national research institutes specializing in biosciences, protein biochemistry, and molecular technologies. She has authored 108 documents, received 3,717 citations, and holds a 39 h-index, underscoring her strong scientific influence and consistent contributions to peer-reviewed literature indexed in major international databases such as Scopus.

Citation Metrics (Scopus)

5000

4000

3000

2000

1000

0

Citations
3,717

Documents
108

h-index
39

🟦 Citations        🟥 Documents     🟩 h-index

View Scopus Profile

Featured Publications

Production, crystallographic studies, and functional profiling of γ-carbonic anhydrase from the probiotic Limosilactobacillus reuteri: In vitro and cell-based insights – European Journal of Medicinal Chemistry

Tetrazole Derivatives as Multiclass Inhibitors of Bacterial Carbonic Anhydrases – Archiv der Pharmazie

Coumarin-Containing Aromatic Sulfonamides With Carbonic Anhydrase Inhibitory Properties Against Human and Fungal Isoforms – Chemical Biology and Drug Design

Eco-Friendly Synthesis of Chitosan–Fatty Acid Nano Micelles and Their Differential Antibacterial Activity Against Escherichia coli and Bacillus subtilis – Journal of Functional Biomaterials

Acetazolamide-Loaded Nanoparticle Based on Modified Hyaluronic Acid as Delivery System to Target Carbonic Anhydrases in Escherichia coli – International Journal of Molecular Sciences

Shouping Xu | Biology and Life Sciences | Best Researcher Award

Assoc. Prof. Dr. Shouping Xu | Biology and Life Sciences | Best Researcher Award

Assoc. Prof. Dr. Shouping Xu | Biology and Life Sciences | Medical Physicist | Cancer Hospital Chinese Academy of Medical Sciences | China

Assoc. Prof. Dr. Shouping Xu is a distinguished medical physicist specializing in radiation oncology, with extensive expertise in advanced radiotherapy techniques and the integration of artificial intelligence in cancer treatment. He holds degrees in nuclear physics and medical physics from leading Chinese institutions and has served in senior leadership roles as Chief Clinical Medical Physicist at the Cancer Hospital, Chinese Academy of Medical Sciences, and previously at the Chinese PLA General Hospital and Yi Zhou Proton Therapy Center. Assoc. Prof. Dr. Shouping Xu  has made significant contributions to the development of innovative dose prediction models, proton therapy planning, and image-guided radiotherapy, with numerous publications in high-impact international journals. His active engagement in global conferences, memberships in professional societies, and certifications from recognized boards reflect his commitment to advancing medical physics. Widely respected for both his clinical leadership and research excellence, Assoc. Prof. Dr. Shouping Xu continues to play a key role in shaping the future of precision radiotherapy and medical imaging technologies.

Professional Profile 

Education  

Assoc. Prof. Dr. Shouping Xu has a strong academic background in physics and medical physics, beginning with a Bachelor of Science degree in Nuclear Physics Technology from Lanzhou University, China. He went on to pursue advanced studies at Tsinghua University, where he earned a Master of Science degree in Medical Physics from the Department of Engineering Physics, followed by a Doctor of Philosophy in Medical Physics from the same department. His education provided a solid foundation in radiation physics, imaging, and advanced treatment technologies, which has been central to his career in radiation oncology and his contributions to clinical innovation and research in medical physics.

Professional Experience

Assoc. Prof. Dr. Shouping Xu has built an extensive professional career in medical physics, holding key clinical and leadership positions in some of China’s most renowned cancer treatment centers. He currently serves as Chief Clinical Medical Physicist at the Proton Center of the Cancer Hospital, Chinese Academy of Medical Sciences, where he oversees clinical operations, quality management, and research in advanced radiotherapy. Previously, he was Chief Medical Physicist and Vice Director at the Yi Zhou Proton Therapy Center, where he played a pivotal role in establishing clinical workflows and implementing cutting-edge proton and photon therapies. Earlier in his career, he served at the Chinese PLA General Hospital as Chief and Senior Medical Physicist, contributing to innovations in IMRT, image-guided radiotherapy, and quality assurance. With responsibilities ranging from managing multidisciplinary teams to developing clinical protocols and engaging in pioneering research, Assoc. Prof. Dr. Shouping Xu has consistently demonstrated leadership, technical expertise, and a strong commitment to advancing radiation oncology practices.

Research Interest

Assoc. Prof. Dr. Shouping Xu’s research interests lie at the intersection of medical physics, radiation oncology, and artificial intelligence, with a focus on advancing precision radiotherapy. His work emphasizes the development of AI-driven algorithms and deep learning models for dose prediction, treatment planning, and image-guided radiotherapy, aiming to improve both the efficiency and accuracy of cancer treatment. He has conducted extensive studies on proton therapy, CyberKnife radiosurgery, and advanced techniques such as VMAT, IMRT, and adaptive radiotherapy, contributing to innovations in treatment optimization and quality assurance. Additionally, his research explores deformable image registration, dose verification, and the clinical application of AI for enhancing radiotherapy workflows. By bridging physics, engineering, and oncology, Assoc. Prof. Dr. Shouping Xu is committed to translating cutting-edge technologies into practical clinical tools that improve outcomes and safety for cancer patients.

Award and Honor

Assoc. Prof. Dr. Shouping Xu has earned recognition for his significant contributions to medical physics and radiation oncology through his active involvement in international conferences, professional societies, and research achievements. He has been an invited speaker and presenter at prestigious forums such as the AAPM Annual Meetings, the IUPESM World Congress on Medical Physics and Biomedical Engineering, and the Asia-Oceania Congress of Medical Physics, where his work on advanced radiotherapy techniques and AI-driven innovations has been highlighted. His leadership roles as Chief Clinical Medical Physicist and his certifications from the Chinese Board of Medical Physicists (CBMP) and the Chinese Board of Radiation Protection (CBRP) further underscore his professional excellence. Through his research, publications, and professional service, Assoc. Prof. Dr. Shouping Xu has gained both national and international recognition, reflecting his status as a highly respected figure in the field of medical physics.

Publications Top Noted

Dosimetric evaluation of intensity modulated proton therapy and photon volumetric modulated arc therapy for bilateral breast cancer
Year: 2025

Virtual-simulation boosted neural network dose calculation engine for intensity-modulated radiation therapy
Year: 2025

Dose rate correction of a diode array for universal wedge field dosimetric verification
Year: 2025

gMCAP: a GPU-based Monte Carlo proton transport program for high-density tissues with precise nuclear reaction models
Year: 2025

An AI dose-influence matrix engine for robust pencil beam scanning protons therapy
Year: 2025

A feasibility study of dose-band prediction in radiation therapy: Predicting a spectrum of plan dose
Year: 2025

A StarGAN and transformer-based hybrid classification-regression model for multi-institution VMAT patient-specific quality assurance
Year: 2025

Dose prediction of CyberKnife Monte Carlo plan for lung cancer patients based on deep learning: robust learning of variable beam configurations
Year: 2024

Dosimetric comparison of ZAP-X, Gamma Knife, and CyberKnife stereotactic radiosurgery for single brain metastasis
Year: 2024

Conclusion

Assoc. Prof. Dr. Shouping Xu is highly suitable for the Best Researcher Award. His combination of clinical leadership, innovative research in AI-driven radiation therapy, and active participation in international scientific forums positions him as a thought leader in medical physics and oncology. With his strong portfolio of publications and pioneering approaches to radiation therapy planning and quality assurance, he demonstrates both scientific excellence and clinical relevance. With further emphasis on international collaborations and translational outcomes, his contributions will continue to shape the future of precision radiotherapy.

Jwee Chiek Er | Biology and Life Sciences | Pioneer Researcher Award

Jwee Chiek Er | Biology and Life Sciences | Pioneer Researcher Award

Researcher, Norwegian Veterinary Institution, Norway

Dr. Jwee Chiek Er is a distinguished veterinary epidemiologist and researcher dedicated to advancing animal health. 🐖📈 Since 2007, he has worked full-time at the Norwegian Veterinary Institute, focusing on epidemiology and bioinformatics. 🇳🇴🔬 He also serves part-time as a church servant at Uranienborg Menighet since 2020. ⛪ Previously, Dr. Er contributed significantly to veterinary inspection in Singapore’s pig and poultry slaughterhouses (1991–2006) and served as a Captain in the Singapore Armed Forces (1989–1991). 🛡️🏥 With a Ph.D. from the University of Life Sciences, Norway, an MPVM from UC Davis, and a BVSc from the University of Queensland, Dr. Er’s career blends scientific excellence with public service. 🎓🌍 His pioneering research on influenza A(H1N1)pdm09 virus infection in pigs has had lasting impacts on veterinary public health. 🦠📖 A committed scholar with 14 peer-reviewed publications, Dr. Er exemplifies the qualities honored by the Pioneer Researcher Award. 🏆✨

Publication  Profile

Orcid

Education 

Dr. Jwee Chiek Er holds a rich academic background dedicated to veterinary science and epidemiology. 🎓🐾 He earned his Ph.D. in 2006 from the University of Life Sciences, Oslo, Norway, presenting a landmark thesis on epidemiological studies of influenza A(H1N1)pdm09 virus infections in Norwegian pigs. 🇳🇴📚 He pursued his Master’s in Preventive Veterinary Medicine (MPVM) at the prestigious University of California, Davis, USA, graduating in 2000 with a focus on Veterinary Epidemiology. 🇺🇸📊 Dr. Er began his academic journey with a Bachelor of Veterinary Science (BVSc) from the University of Queensland, Australia, in 1989, grounding him firmly in veterinary practice. 🇦🇺🩺 His education reflects a lifelong commitment to enhancing animal health and advancing veterinary epidemiology through global learning experiences, interdisciplinary knowledge, and applied research, making him a fitting nominee for the Pioneer Researcher Award. 🏅🌟

Experience 

Dr. Jwee Chiek Er’s professional journey reflects outstanding dedication across diverse fields. 🌟 From 2007 onwards, he has been a full-time researcher at the Norwegian Veterinary Institute, specializing in epidemiology and bioinformatics. 🐷📊 In 2020, he also took on part-time service as a church servant at Uranienborg Menighet, den norsk luthersk kirke. ⛪ Before his research career, Dr. Er served in Singapore’s civil service (1991–2006), ensuring veterinary inspection and public health in pig and poultry slaughterhouses. 🐔🔍 He started his career in national service, where he rose to the rank of Captain in the Singapore Armed Forces as a logistics officer (1989–1991). 🎖️🚛 These extensive experiences demonstrate his leadership, scientific expertise, and commitment to public welfare. His professional background embodies the spirit of perseverance and innovation celebrated by the Pioneer Researcher Award. 🏅📈

Awards and Honors 

Dr. Jwee Chiek Er’s career is a testament to persistent excellence and leadership. 🌟 Although specific award listings were not detailed, his achievements themselves reflect high recognition in the veterinary science community. 🐾📈 His Ph.D. thesis and impactful peer-reviewed publications have significantly advanced knowledge of influenza epidemiology in pig populations, demonstrating award-worthy innovation. 🦠🔬 His pioneering surveillance work on influenza A(H1N1)pdm09 infections in Norway greatly contributed to national animal health strategies. 🇳🇴🐖 Furthermore, Dr. Er’s role in public veterinary service in Singapore and his distinguished service in the Singapore Armed Forces earned him respect and authority early in his career. 🎖️🌏 Nomination for the Pioneer Researcher Award is a fitting tribute to his lifelong dedication to animal health, epidemiological innovation, and scientific leadership. 🏅📚 His work bridges practice and research, influencing veterinary policies across nations. 🌐✨

Research Focus 

Dr. Jwee Chiek Er’s research centers on the epidemiology of infectious diseases in animal populations, with a strong focus on influenza A(H1N1)pdm09 virus in pigs. 🐖🦠 His studies analyze infection patterns, serosurveillance, and economic impacts on animal health, providing essential insights for disease control and public health policy. 📊🛡️ Using bioinformatics and mathematical modeling, such as discrete-time Markov Chain modeling, he projects disease prevalence and evaluates herd-level interventions. 📈🖥️ His research also explores serological cross-reactivity between influenza strains, crucial for improving diagnostic and surveillance systems. 🧬🔍 Through longitudinal studies at boar testing stations and comprehensive serological surveys, Dr. Er has significantly advanced understanding of viral behavior in livestock. 📑📈 His interdisciplinary approach integrating epidemiology, economics, and computational tools highlights him as a pioneer in veterinary research. 🏆🔬 His work supports healthier livestock systems and contributes to global food security. 🌍🍖

Publications Top Notes

  • 📄 “Adverse Effects of Influenza A(H1N1)Pdm09 Virus Infection on Growth Performance of Norwegian Pigs – a Longitudinal Study at a Boar Testing Station” (BMC Vet Res, 2014)

  • 📄 “Occurrence and Spread of Influenza A(H1N1)Pdm09 Virus Infection in Norwegian Pig Herds Based on Active Serosurveillance from 2010 to 2014” (Epidemiol Infect, 2016)

  • 📄 “Production Impact of Influenza A(H1N1)Pdm09 Virus Infection on Fattening Pigs in Norway” (J Anim Sci, 2016)

  • 📄 “Longitudinal Projection of Herd Prevalence of Influenza A(H1N1)Pdm09 Virus Infection in the Norwegian Pig Population by Discrete-Time Markov Chain Modelling” (Infectious Disease Reports, 2021)

  • 📄 “Antibodies of Influenza A(H1N1)Pdm09 Virus in Pigs’ Sera Cross-React with Other Influenza A Virus Subtypes: A Retrospective Epidemiological Interpretation of Norway’s Serosurveillance Data from 2009–2017” (Epidemiology and Infection, 2020)

  • 📄 “A Survey of Skin Neoplasms in Dogs from the Brisbane Region” (Aust Vet J, 1989)

Tawanda Chivese | Medicine and Health Sciences | Best Researcher Award

Tawanda Chivese | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Tawanda Chivese, University of Washington Tacoma, United States

Assist. Prof. Dr. Tawanda Chivese is an accomplished epidemiologist specializing in clinical epidemiology. With a Ph.D. in Medicine from the University of Cape Town, and an MSc (cum laude) in Clinical Epidemiology from Stellenbosch University, Dr. Chivese has a strong foundation in advanced epidemiological methods, biostatistics, and global health. He is currently an Assistant Professor of Epidemiology at the University of Washington Tacoma, and an Extraordinary Senior Lecturer at Stellenbosch University. Over his career, Dr. Chivese has led impactful international research on diabetes, gestational diabetes, cardiometabolic diseases, and mental health outcomes. His work has been published in high-impact peer-reviewed journals, and he actively contributes as a journal reviewer and editorial board member. Dr. Chivese’s commitment to academic excellence, mentorship, and research collaboration marks him as a distinguished researcher with significant contributions to global public health.

Publication Profile

Orcid

Education

Dr. Tawanda Chivese holds a Ph.D. in Medicine (2021) from the University of Cape Town, where he investigated the long-term effects of hyperglycemia in pregnancy on offspring obesity and cardiovascular risk. He earned his MSc Clinical Epidemiology (cum laude, 2014) from Stellenbosch University, completing advanced coursework in epidemiology, biostatistics, and systematic reviews. His Master’s research focused on cigarette smoking and Crohn’s Disease phenotypes. Earlier, he completed a Bachelor of Science (Honours) in Nursing Science (2006) from the University of Zimbabwe, developing a strong clinical foundation. He has supplemented his formal education with specialized training in systematic reviews, digital skills, blended learning, biomedical ethics, and diagnostic test accuracy through global institutions like the University of Birmingham and the University of Oxford. Dr. Chivese’s comprehensive education underpins his expertise in clinical epidemiology and global health research.

Experience

Dr. Chivese is currently an Assistant Professor (tenure-track) at the University of Washington Tacoma (2024-present), leading epidemiology and public health teaching, collaborative research on gestational diabetes, and supervising student research. Previously, he served as Assistant Professor at Qatar University (2019-2024), where he coordinated key courses, redesigned epidemiology curricula, and mentored over 100 student researchers, many winning top awards. He fostered collaborations with the Qatar Ministry of Public Health and Qatar Biobank. Concurrently, Dr. Chivese has held honorary positions at Stellenbosch University and the South African Medical Research Council since 2016. His experience combines academic leadership, innovative teaching, curriculum development, large-scale collaborative research, and scholarly publication. His global impact is evidenced by partnerships across Africa, the Middle East, and the U.S., positioning him as a leading figure in global clinical epidemiology.

Awards and Honors

Dr. Tawanda Chivese’s dedication to excellence has earned him multiple accolades. He received consistent teaching excellence awards during his tenure at Qatar University and awards for supervising the best undergraduate research projects. His leadership contributions to the Public Health Association of South Africa, serving on the executive board and as Vice Chairperson for a special interest group, underline his influence in public health leadership. His scholarly work has been recognized with prestigious grants, including funding from Qatar Foundation, Welcome Trust, and SAMRC/Newton Fund. In addition, he has been selected as an editorial board member for BMC Public Health and frequently reviews for top-tier journals like The Lancet and PLOS Medicine. These honors reflect his outstanding achievements in research, teaching, mentorship, and service to the academic and public health communities.

Research Focus

Dr. Chivese’s research primarily focuses on the intersection of metabolic and mental health diseases, particularly diabetes, cardiovascular risks, and cognitive outcomes post-gestational diabetes. He specializes in clinical epidemiology, meta-analysis, and diagnostic accuracy studies. His recent projects include investigating the developmental origins of autism spectrum disorders, the role of poor glycemic control in cognitive dysfunction, and refining meta-analysis methods for improved evidence synthesis. He also leads collaborative studies on lifestyle interventions to prevent cardiometabolic diseases in high-risk populations. His work aims to uncover critical determinants of chronic disease progression and provide actionable public health interventions. Dr. Chivese’s research approach is interdisciplinary, combining clinical insight, advanced statistical methods, and global collaboration to address complex health challenges in both low- and high-income settings.

Publication Top Notes

Buddhi Fernando | Biology and Life Sciences | Best Researcher Award

Buddhi Fernando | Biology and Life Sciences | Best Researcher Award

Dr Buddhi Fernando, Department of MLS, Faculty of Allied Health Sciences, University of Ruhuna, Galle, Sri Lanka

Dr. Buddhi Fernando is a dedicated academic and clinical biochemist from Sri Lanka 🇱🇰, currently serving as a Lecturer at the Department of Medical Laboratory Science, Faculty of Allied Health Sciences, University of Ruhuna. With a Ph.D. in Clinical Biochemistry from the University of Peradeniya 🎓, Dr. Fernando has pioneered studies on Chronic Kidney Disease of uncertain etiology (CKDu), identifying biomarkers for diagnosis, staging, and risk prediction 🧬🩺. With experience in teaching Clinical Biochemistry, Andrology, Microbiology, and more, she has inspired many students while conducting impactful research. Her award-winning research presentations and global exposure, including a scholarship to Japan 🌏, reflect her academic excellence. Dr. Fernando has co-authored numerous high-impact publications in reputed journals and remains passionate about translational science that directly benefits vulnerable communities. Her persistent pursuit of knowledge, interdisciplinary collaborations, and commitment to public health place her among Sri Lanka’s most promising researchers 🌟📚🔬.

Publication Profile

Google Scholar 

Education

Dr. Buddhi Fernando completed her Ph.D. in Clinical Biochemistry 🧪 at the Faculty of Medicine, University of Peradeniya, Sri Lanka, in 2020. Her dissertation focused on identifying a biomarker profile for CKDu and evaluating its utility in early diagnosis, staging, and risk stratification 🧬📊. She earned her B.Sc. in Medical Laboratory Science with a Second-Class Upper Division in 2014 from the Faculty of Allied Health Sciences, University of Peradeniya 🏥🔍. Her undergraduate research explored the impact of Diabetes Mellitus on heart function in ICR mice 🐭❤️. Earlier, she completed the G.C.E. Advanced Level Examination (2008) and G.C.E. Ordinary Level Examination (2002) with commendable results 🎓📘. Dr. Fernando’s academic training merges rigorous scientific methodology with a strong focus on public health relevance, especially in addressing rural disease burdens. Her scholarly foundation has been crucial in supporting her innovative research into CKDu, a condition affecting thousands in Sri Lanka 🩺🌱.

Experience

Dr. Buddhi Fernando has over six years of academic and teaching experience 📚. From November 2019 to date, she has served as a Lecturer (Probationary and then permanent) at the Department of Medical Laboratory Science, University of Ruhuna 🏫. Her teaching responsibilities span Clinical Biochemistry, Microbiology, Andrology, Physiology, and Parasitology 🧫🧠. She has also taken on leadership roles as Batch Coordinator and Unit Coordinator. Previously, she was a Demonstrator at the University of Peradeniya (2018–2019) and a Lecturer at IVA Para Medical Campus, Kandy (2018) 🧪. She is registered with the Sri Lanka Medical Council (Reg. No. 2478) 🧾. Her hands-on academic guidance and innovative methodologies help bridge theoretical learning with practical healthcare applications. Dr. Fernando’s commitment to education and mentorship has left a positive impact on future generations of medical laboratory professionals.

Awards and Honors

Dr. Buddhi Fernando’s excellence in research and academia has earned her several prestigious accolades 🌟. In 2012, she was awarded a scholarship for the Global Health Student Exchange Program at Niigata University, Japan, recognizing her early promise in global public health 🌍🇯🇵. In 2017, she won First Place for the Best Oral Presentation at the Research Sessions of the Kandy Society of Medicine 🥇🎤, showcasing her talent in communicating scientific breakthroughs effectively. Her outstanding scholarly output is reflected in numerous publications across high-impact journals such as PLoS ONE, Kidney International Reports, and Environmental Geochemistry and Health 📑📈. As a unit coordinator and mentor, her academic leadership has also been instrumental in enhancing research culture among peers and students 🧑‍🎓🔬. These honors exemplify her capability to contribute significantly to science, education, and community health — making her a strong contender for the Best Researcher Award 🏅📚🧪.

Research Focus

Dr. Buddhi Fernando’s research primarily centers on Chronic Kidney Disease of uncertain etiology (CKDu)—a pressing health crisis in Sri Lanka’s rural communities 🏞️🩺. Her Ph.D. work focused on identifying biomarker templates for CKDu and evaluating their utility for early detection, population screening, diagnosis, staging, and predicting complications 🧬💉. Her multidisciplinary approach integrates biochemical profiling, environmental toxicology, and molecular diagnostics to uncover the complex pathophysiology of CKDu. Beyond CKDu, she also explores diabetes-related cardiac effects and trace element imbalances ⚖️❤️. Dr. Fernando’s work has high translational value, aiming to bridge the gap between laboratory science and community health solutions 🧪🤝. Her collaborations with nephrologists, toxicologists, and global health experts reflect her broad academic network and research adaptability 🌐. Her contributions are vital to designing affordable, effective diagnostics for low-resource settings — making her research both locally relevant and globally significant 🌎📊🧠.

Publication Top Notes

Serum and urine fluoride levels in populations of high environmental fluoride exposure with endemic CKDu: a case–control study from Sri Lanka